Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk

被引：0
|
作者：
Vitolo, Marco [1 ,2 ]
Gerra, Luigi [1 ]
Boriani, Giuseppe [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Cardiol Div, Policlin Modena, Modena, Italy
[2] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2024年 / 119卷
关键词：
Atrial fibrillation; End -stage renal disease; Oral anticoagulants; Dialysis; NOACs; Chronic kidney disease; HEMODIALYSIS; APIXABAN; STROKE;
D O I：
10.1016/j.ejim.2023.10.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 41
页数：3
相关论文
共 50 条
  • [31] Management of bleeding with oral anticoagulants in patients with atrial fibrillation
    Bosch, J.
    Eikelboom, J. W.
    [J]. HAMOSTASEOLOGIE, 2015, 35 (04): : 351 - 357
  • [32] Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease The Problem of Observational Studies
    Meuwese, Christiaan Lucas
    Kooiman, Judith
    van Diepen, Merel
    Carrero, Juan Jesus
    [J]. CHEST, 2016, 150 (04) : 981 - 981
  • [33] Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Ronco, Federico
    Mazzone, Patrizio
    Hosseinian, Leila
    Genovesi, Simonetta
    [J]. CARDIORENAL MEDICINE, 2017, 7 (03) : 207 - 217
  • [34] Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
    Goel, Narender
    Jain, Deepika
    Haddad, Danny B.
    Shanbhogue, Divya
    [J]. JOURNAL OF STROKE, 2020, 22 (03) : 306 - 316
  • [35] Anticoagulation for Patients With Atrial Fibrillation and End-Stage Renal Disease on Dialysis: A National Survey
    Halperin, Laura F.
    Lee, May K.
    Liew, Janet
    Lauck, Sandra
    Kong, Darren
    Krahn, Andrew D.
    Deyell, Marc W.
    Andrade, Jason G.
    Hawkins, Nathaniel M.
    Chakrabarti, Santabhanu
    Yeung-Lai-Wah, Ah Fan John
    Bennett, Matthew T.
    Cheung, Christopher
    Levin, Adeera
    Schwartz, Daniel I.
    Laksman, Zachary W.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (06) : 924 - 928
  • [36] Electrocardiographic predictors of the future development of atrial fibrillation in patients with end-stage renal disease
    Chung, H.
    Lee, J. M. L.
    Woo, J. S. W.
    Kim, J. B. K.
    Kim, S. J. K.
    Kim, W. K.
    Kim, W. S. K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 567 - 567
  • [37] Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
    Lip, Gregory Y. H.
    Keshishian, Allison, V
    Zhang, Yan
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Ferri, Mauricio
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    [J]. JAMA NETWORK OPEN, 2021, 4 (08) : E2120064
  • [38] Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation
    Overvad, Thure F.
    Larsen, Torben B.
    Albertsen, Ida E.
    Rasmussen, Lars H.
    Lip, Gregory Y. H.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (12) : 1619 - 1629
  • [39] Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease
    Ho, Li-Ting
    Lin, Lian-Yu
    Yang, Yao-Hsu
    Wu, Cho-Kai
    Juang, Jyh-Ming Jimmy
    Wang, Yi-Chih
    Tsai, Chia-Ti
    Lai, Ling-Ping
    Hwang, Juey-Jen
    Chiang, Fu-Tien
    Lin, Jiunn-Lee
    Chen, Pau-Chung
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 538 - 543
  • [40] Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation
    Jackevicius, Cynthia A.
    Lu, Lingyun
    Ghaznavi, Zunera
    Warner, Alberta L.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (02): : 155 - 168
12345